Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Sun Pharmaceutical Industries Ltd. said Monday that a U.S. appellate court affirmed a summary judgment in its favor in an antitrust lawsuit involving a 2008 patent litigation settlement with Pfizer. The case centered on allegations that the…
S&CO Inc. Buys Shares of 358,302 Royalty Pharma PLC $RPRX
S&CO Inc. bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought…
NewAmsterdam Pharma Company N.V. $NAMS Shares Sold by Handelsbanken Fonder AB
Handelsbanken Fonder AB lessened its holdings in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 70.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional…
Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside (NYSE:TMO)
Thermo Fisher Scientific is rated a Buy, supported by accelerating organic growth and improving Pharma and Biotech end markets. TMO's recent acquisitions of Clario and Solventum's Filtration and Separation business expand capabilities, enabling…
SpaceMD will use Starfall to launch its creation of space pharmaceuticals
Redwire, working through its space-based pharmaceutical subsidiary, SpaceMD, has bought the first operational flight of the SpaceX Starfall to continue the research and development of drugs using microgravity to improve their potency and other…
TV tonight: a remarkable Bafta-winning film gets a vital update
Mir Hussein was eight years old when he first saw a camera in 2002. Documentary-makers Phil Grabsky and Shoaib Sharifi filmed him and his family in Afghanistan when US troops arrived, and followed him for two decades as he grew up and became a…
We Cannot Ignore Her': Fauci Resisted Studying Vaccine Side Effects Despite FDA Official's Pressure
A “blinking red” email from Anthony Fauci's government account is raising another round of questions about what top federal health officials knew about potential COVID-19 vaccine side effects — and how far they may have gone to…
Wall Street Week Ahead
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Spotify. Up for a challenge? Test your knowledge on the biggest events in the investing world over the past week. Take the latest…
Why cancer, not cost of living, may be the biggest issue in Iowa's midterm elections
In Iowa, one of the key battleground states in November's midterm elections, just about every political candidate agrees on one thing: something must be done about the state's rising rates of cancer. The midwestern state has the second-highest rate…
Sensex, Nifty open lower as crude oil prices, geopolitical tensions weigh
Markets opened on a weak note on Monday, with the Nifty 50 slipping 66.85 points or 0.27 per cent to 24,299.15 and the Sensex falling 305.23 points or 0.39 per cent to 77,704.02, as elevated crude oil prices and Middle East tensions continued to…
The L.A. Lakers Delivered a 1-Year Return of 25%. These ETFs Have Done Even Better.
Would you rather own the Los Angeles Lakers or a diversified stock ETF? One of the NBA's most iconic franchises is being sold to new owners for $12.5 billion. About a year ago, the Lakers sold for $10 billion. That means the soon-to-be-former owner…
Best Healthcare Stocks To Follow Today - August 16th
The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, AbbVie, Stryker, Merck & Co., Inc., and CVS Health are the seven Healthcare stocks to watch today…
S&CO Inc. Takes Position in Astrazeneca Plc $AZN
S&CO Inc. purchased a new stake in shares of Astrazeneca Plc (NYSE:AZN - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 37,990 shares of the…
Among the chaos of Edinburgh's Fringe there is an urgent story being told
The shameful trade in prescription opioids – such as OxyContin, which was peddled by the recently dissolved US firm Purdue Pharma – is the subject of the astonishing new opera The Galloping Cure (Festival Theatre, run ended).
Centric Wealth Management Takes $3.52 Million Position in Gilead Sciences, Inc. $GILD
Centric Wealth Management acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…
Receive a Daily briefing on Pharma Industry News
Get Started